Table 4 Prevalence of use of different antihypertensive drug classes in patients below and above the high cardiovascular risk VAI cutoff value
|  | β-blockers | ACEIs | ARBs | CCBs | Diuretics | α1 adrenergic blockers |
|---|---|---|---|---|---|---|
Whole population (n = 129) | 45 (34.9) | 39 (30.2) | 55 (42.9) | 25 (19.4) | 60 (46.9) | 7 (5.4) |
 VAI class 0 (n = 70) | 25 (35.7) | 25 (35.7) | 24 (34.3)* | 10 (14.3) | 33 (47.1) | 4 (5.7) |
 VAI class I (n = 59) | 20 (33.9) | 14 (23.7) | 31 (52.5) | 15 (25.4) | 27 (45.8) | 3 (5.1) |
Only antihypertensive (n = 104) | 35 (33.7) | 33 (31.7) | 45 (43.3) | 20 (18.3) | 48 (46.2) | 4 (3.7) |
 VAI class 0 (n = 60) | 18 (30.0) | 21 (35.0) | 22 (36.7) | 9 (15) | 29 (48.3) | 2 (3.3) |
 VAI class I (n = 44) | 17 (38.6) | 12 (27.3) | 23 (52.3) | 11 (25) | 19 (43.2) | 2 (4.5) |